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ABSTRACT Three distinct transforming genes present in hu-
man-tumor cell lines are all related to the viral oncogenes of Harvey
and Kirsten murine sarcoma viruses, designated v-H-ras and v-K-
ras, respectively. The transforming gene of a bladder carcinoma
cell line has been shown to be a human homolog to v-H-ras [Par-
ada, L. F., Tabin, C. J., Shih, C. &Weinberg, R. A. (1982) Nature(London) 297, 474-478; Santos, E., Tronick, S. R., Aaronson, S.
A., Pulciani, S. & Barbacid, M. (1982) Nature (London) 298, 343-
3471. The transforming gene common to one colon (SK-CO-1) and
two lung carcinoma (SK-LU-1 and Calu-1) cell lines is the same
human homolog of v-K-ras as is the transforming gene previously
identified in a lung carcinoma cell line Lx-l [Der, C. J., Krontiris,
T. G. & Cooper, G. M. (1982) Proc. Nati. Acad. Sci. USA 79, 3637-
3640]. The transforming gene of SK-N-SH neuroblastoma cells is
weakly homologous to both v-H-ras and v-K-ras. NIH 3T3 cells
transformed with the SK-N-SH transforming gene contain in-
creased levels of a protein serologically and structurally related
to the protein products of the v-H-ras and v-K-ras genes. There-
fore, it represents a third member of the ras gene family, which
we have called N-ras. Based on the homology with the v-ras genes,
we have established the orientation of transcription and approx-
imate coding regions of the cloned human K-ras and N-ras genes.
The progression of a cell from normalcy to malignancy may be
due in part to the activation of transforming genes of cellular
origin. The existence of cellular transforming genes has been
demonstrated by the ability of genomic DNAs from certain tu-
mors and cell lines to induce foci of transformed NIH 3T3 cells
after DNA-mediated gene transfer. Transforming genes in ro-
dent (1, 2) and human (3-9) tumor cells have been detected in
this way. We have detected three distinct transforming genes
in our study of 21 human tumor cell lines: one common to two
lung carcinoma (SK-LU-1 and Calu-1) and colon carcinoma (SK-
CO-1) cell lines, one in a bladder carcinoma (T24), and one in
a neuroblastoma (SK-N-SH) cell line (9).
Several research groups have shown that certain transform-
ing genes detected by transfer to NIH 3T3 cells are related to
viral oncogenes. Der et al. (5), Parada et al. (10), and Santos et
al. (11) have demonstrated that the transforming gene of T24
and EJ, two human bladder carcinoma cell lines that probably
are derived from the same source (unpublished data), is the hu-
man homolog of v-H-ras, the oncogene of the Harvey sarcoma
virus. Der et al. (5) have also shown that the transforming gene
of Lx-i, a human lung carcinoma cell line, is a human homolog
of v-K-ras, the oncogene of the Kirsten sarcoma virus. The genes
that we have isolated from human tumor cell lines are related
also to the viral oncogenes, designated v-onc. We demonstrate
that the transforming gene common to Calu-1, SK-LU-1, and
SK-CO-1, like the transforming gene in Lx-1 characterized by
Der et al. (5), is a human homolog to v-K-ras. We also dem-
onstrate that the transforming gene of SK-N-SH is related to
both v-K-ras and v-H-ras and probably codes for an immu-
nologically crossreactive and structurally related protein. Based
on the homology with the v-ras genes, we have established the
orientation of transcription and probable coding regions of these
genes.
MATERIALS AND METHODS
Human Tissue and Tissue Culture Cell Lines. T24, Calu-1
SK-LU-1, SK-CO-1, and SK-N-SH are human tumor cell lines
(9). HT14B is a NIH 3T3 cell line transformed by Harvey sar-
coma virus unintegrated viral DNA. Other transformed cell lines
are described in the text.
Preparation of DNA. DNA was prepared from tissue culture
cells by NaDodSO4/proteinase-K lysis and phenol/chloroform
extraction as described (9). Plasmid and bacteriophage DNAs
were prepared as described (12, 13).
Enzymes. Restriction endonucleases were purchased from
New England BioLabs and Bethesda Research Laboratories and
used according to suppliers' instructions. E. coli DNA poly-
merase I was purchased from Bethesda Research Laboratories,
and pancreatic DNase I was from Worthington Biochemicals.
Southern Filter DNA Blot Hybridization. DNA samples were
digested with restriction endonucleases and subjected to agar-
ose gel electrophoresis and filter-blot transfer by the method of
Southern (14). Filter-blotted DNAs were hybridized with a nick-
translated 32P-labeled DNA probe under two sets of conditions.
Stringent hybridization conditions entailed hybridization in a
mixture containing 6x NaCl/Cit (ix NaCl/Cit is 0.15 M NaCl/
0.015 M Na citrate, pH 7.0), Denhardt's solution (0.02% poly-
vinylpyrrolidone/0.02% Ficoll/0.2% bovine serum albumin),
and denatured salmon sperm DNA (20 Aug/ml) for 16 hr at 740C(15), followed by sequential washing at 740C with 2 x, 1x, and
0.5x NaCl/Cit in 0.1% NaDodSO4. Nonstringent hybridiza-
tion conditions entailed hybridization in a mixture containing
30% (vol/vol) formamide, 6x NaCl/Cit, 2X Denhardt's so-
lution, E. coli DNA (100 Ag/ml), yeast RNA (200 tug/ml), 50
mM sodium phosphate (pH 7), and 10 mM EDTA at 370C for
36 hr, followed by washing at 50'C in 6X NaCl/Cit/0.1%
NaDodSO4. Hybridized DNA was revealed by autoradiogra-
phy.
Immunoprecipitation of Cellular Protein with Rat Anti-ras
p21 Antiserum. NIH 3T3 normal and transformed cells were
Abbreviations: NaCl/Cit, 0.15 M sodium chloride/0.015 M sodium ci-
trate, pH 7.0; kbp, kilobase pairs.
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labeled in methionine-free medium containing 20 jiCi (1 Ci =
3.7 X 10'° Bq) of [35S]methionine per ml (New England Nu-
clear) for 18 hr. Labeled cells were lysed in phosphate-buffered
saline containing 1% Triton X-100, 0.5% sodium deoxycholate,
1 mM phenylmethylsulfonyl fluoride, and 2 units of aprotinin
per ml, and the lysates were sheared through a syringe and clar-
ified at 100,000 X g for 45 min at 40C. Clarified supernatants
were preabsorbed with goat anti-rat IgG and Staphylococcus
aureus protein A. Immunoprecipitation was performed with anti-
v-H-ras p21 rat monoclonal antibody Y13-259 (16) (the gift of
M. Furth and E. M. Scolnick) for 5 hr at 40C, followed by ad-
dition of goat anti-rat IgG for 1 hr. Immune complexes were
absorbed to protein A, and the protein A suspension was washed
extensively in lysis buffer. Protein A pellets were boiled in Na-
DodSO4 sample buffer and analyzed by NaDodSO4/poly-
acrylamide gel electrophoresis by the method of Blattler et al.
(17). Radiolabeled proteins in gels were visualized by fluorog-
raphy.
Molecular Clones. Clones of avian and mammalian v-onc genes
are described in Table 1. AT24 and AP3 are clones from AL47. 1
genomic libraries containing the transforming gene of the T24
cell line and the nontransforming homologous human se-
quences, respectively (25). pT24 is a pBR322 derivative with a
6.2-kilobase-pair (kbp) BamHI insert bearing the T24 trans-
forming gene. The SK-N-SH transforming gene is contained on
a Charon 4A recombinant phage, ANPS-1-1-1 as described (26).
(See also Fig. 4B.) ANPS-1-1-1 also contains portions ofpBR322
and the E. coli tRNA sup F gene.
Cloning the Transforming Gene of Calu-1. An initial DNA
clone of part of the transforming sequences of the Calu-1 trans-
forming gene was obtained by using the strategy of Gusella et
al. (27) as described by others (28, 29). DNA was prepared from
NIH 3T3 secondary and tertiary transformants containing the
Table 1. Molecular clones of v-onc genes
Restriction
v-onc fragments
desig- Virus of Molecular bearing
nation origin* clone v-onc Ref. no.
fpst PRCII SV pRClI-lB Kpn I 1.5 kbp M. Bishop*
yest Y73 SV AY73-11A Sst I 4.0 kbp 18
relt ARVT prel EcoRI 0.8 kbp 19
skit SKV pvski-1 Xho I 2.8 kbp Unpublished
data
abl§ Abelson pABsub3 HindII/Sst II 20
MuLV 2.0 kbp
fes§ Feline SV pGA- Pst I 0.5, 0.55 21
FeSV kbp
mos§ Moloney pmos-1 Pst I 0.45 kbp D. Dina*
MuSV
H-ras§ Harvey pBS-9 EcoRI 0.5 kbp 22
MuSV pHB-ll EcoRI/BamHI 22
2.2 kbp
K-ras§ Kirsten pHiHi-3 EcoRI 1.0 kbp 22
MuSV pKBE-2 EcoRI/BamHI 22
3.1 kbp
fins§ McDonough ASM- Kpn I 2.8, 4.8 23
feline SV FeSV kbp
sis§ Simian SV pvsis EcoRI/Sal I 2.1 24
kbp
The table lists the v-onc sequences that were tested for homology to
three human transforming genes.
* SV, simian virus; ARVT, avian reticuloendotheliosis virus T; SKV,
Sloan-Kettering virus; Mu, murine.
tAvian.
i Personal communication.
§ Mammalian.
transforming gene of Calu-1. Phage libraries were prepared from
these DNAs in A Charon 4A (30) by the method of Hohn and
Murray (31) and screened for the presence of human sequence
by the method of Benton and Davis (32); the probe was "BLUR8",
a clone of the dispersed, repeated human "Alu" family se-
quences (33). One A phage clone, AL2-34, was isolated this way.
Unique sequence DNAs from this clone were then used as probes
for isolating "contiguous" DNA from our A Charon 4A libraries.
More than 20 independent phages containing inserts with over-
lapping restriction endonuclease maps were isolated in this
manner. A representative set of five overlapping phage isolates,
together with a composite restriction endonuclease map of 26
kbp of cloned DNA, is shown in Fig. 4A. pLC3 is the 3.0-kbp
EcoRI fragment of AL2-11 cloned into the EcoRI site of pBR322
(see Fig. 4A).
RESULTS
Three Human Transforming Genes Have Homology to Viral
ras Genes. Molecular clones of v-onc were cleaved with re-
striction endonucleases to separate v-onc and vector sequences,
and triplicate aliquots of these digests were subjected to agar-
ose gel electrophoresis and Southern nitrocellulose filter blot-
ting. The three replica filters were hybridized at low stringency
to 32P-labeled recombinant DNAs containing all or part of the
three different human transforming genes (Fig. 1). The trans-
forming human genes were those isolated from the bladder car-
cinoma cell line T24 (Fig. 1B), the lung carcinoma cell line Calu-
1 (Fig. 1C), and the neuroblastoma cell line SK-N-SH (Fig. 1D).
All three human transforming genes showed homology to v-
H-ras and v-K-ras (Fig. 1, lanes 8-11). The human transforming
genes were not homologous to nine other v-onc genes (Fig. 1,
lanes 1-7, 12, and 13). The hybridization detected in other lanes
of this figure represent hybridization between pBR322 plasmid
and A phage DNA sequences in the probes and on the filters.
It is not surprising that each human transforming gene that hy-
bridized with one also hybridized with both v-H-ras and v-K-
ras because these v-onc genes share sequence homology and
encode immunologically and structurally related proteins (22).
To explore further the homology between these genes, we
hybridized each v-ras gene separately under conditions of high
stringency to Southern blotted DNAs of the T24, SK-N-SH,
and Calu-1 transforming genes and to pBR322 clones contain-
ing v-H-ras and v-K-ras (Fig. 2). As expected, v-H-ras hybrid-
ized well to the T24 transforming gene (Fig. 2A, lane c) and to
the normal allele of this gene (Fig. 2A, lane d). The v-H-ras
probe hybridized only weakly to a 3.0-kbp EcoRI restriction
endonuclease fragment of the Calu-1 transforming gene (Fig.
2A, lane e) and to two EcoRI DNA fragments of the SK-N-SH
transforming gene (Fig. 2A, lane g). In contrast, the v-K-ras
probe was most closely related to the Calu-1 transforming gene,
hybridizing to 3.1-, 3.0-, and 2.4-kbp EcoRI DNA fragments of
this gene (Fig. 2B, lanes 1 and m). Longer autoradiography of
the filter showed weak hybridization between v-K-ras and the
T24 transforming gene (Fig. 2C, lanes j and k) and the two EcoRI
fragments that comprise the SK-N-SH transforming gene (Fig.
2C, lane n).
In summary, all three human transforming genes shared ho-
mology to the v-ras genes. The T24 transforming gene was clos-
est to v-H-ras, the Calu-1 transforming gene was closest to v-
K-ras, and the SK-N-SH transforming gene was more distantly
related to the v-ras genes.
The Lung and Colon Carcinoma Transforming Gene Is a
Human Homolog of v-K-ras. DNAs from normal and trans-
formed NIH 3T3 cells and from human cells were cleaved with
restriction endonuclease EcoRI and subjected to gel electro-
phoresis and filter-blot hybridization, with the pKBE-2 clone
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FIG. 1. Southern filter hybridization of three human transforming
genes to v-onc DNA sequences. Molecular clones of retroviral onco-
genes were digested with restriction endonucleases to separate onco-
genic sequences from plasmid or bacteriophage DNA vectors. Digests
were subjected to electrophoresis through 1% agarose gels, and the DNAs
were transferred from gels to nitrocellulose filter papers (14). Filters
were hybridized with cloned human transforming gene DNAs, which
had been labeled with 32P by nick translation, and filters were sub-
sequently washed under nonstringent conditions. (A) Ethidium bro-
mide stain of a gel prior to filter transfer (arrows denote restriction en-
donuclease fragments containing v-onc sequences). (B-D) Filter
hybridizations with 32P-labeled pT24 DNA (B), 32P-labeled pLC3 (C),
and 32P-labeled ANPS-1-1-1 (D). Lanes show the v-oncDNA restriction
digests: 1, v-fps Kpn I digest of pRCII-1B; 2, v-yes Sst I purified insert
from AY73-11A; 3, v-rel EcoRI digest of prel; 4, v-ski Xho I purified in-
sert from pvski-1; 5, v-abl HindlII/Sst I digest of pABsub3; 6, v-fes Pst
I digest of pGA-FeSV; 7, v-mos Pst I digest of pmos-1; 8, v-H-ras EcoRI
digest of pBS-9; 9, v-H-rasEcoRl/BamHldigestof pHB-11; 10, v-K-ras
EcoRI digest of pHiHi-3; 11, v-K-ras BamHI/EcoRI digest of pKBE-2;
12, v-fins Kpn I purified inserts from A SM-FeSV; 13, v-sis EcoRI/Sal
I digest of pvsis.
of v-K-ras (22) used as the 32P-labeled hybridization probe (Fig.
3). NIH 3T3 cells transformed with DNA from the lung and
colon carcinoma cells (Fig. 3, lanes 1, 2, and 3) contain K-ras-
related sequences not endogenous to NIH 3T3 (Fig. 3, lane 4).
The newly acquired K-ras-related EcoRI fragments in these
transformed cells comigrated with v-K-ras-related EcoRI frag-
ments prominent in human DNA (Fig. 3, lane 5). These EcoRI
fragments are 2.4, 3.0, 3.1, and -6.7 kbp in size. Only one high
molecular weight K-ras-related EcoRI fragment in human DNA
was not transferred to NIH 3T3 cells. Similar results were ob-
served by Der et al. (5) in NIH 3T3 cells transformed with DNA
from Lx-1, indicating that the same human K-ras homolog is
the transforming gene of these cells.
v-K-ras Homologous Regions of the Calu-1 Transforming
Gene. A large portion (26 kbp) of the transforming gene of the
FIG. 2. Hybridization of v-ras sequence probes to filter-blotted hu-
man transforming gene DNAs. Cloned human transforming gene and
v-ras gene DNAs were cleaved with restriction endonucleases, and du-
plicate aliquots were subjected to 1% agarose gel electrophoresis and
Southern filter blotting. The filters were hybridized with either 32P-la-
beled pHB-11 v-H-ras (lanes a-g) or 32P-labeled pKBE-2 v-K-ras (lanes
h-n). The filters were washed under stringent conditions. Autoradio-
graphic exposures were for 2 hr (A), 12 hr (B), and 72 hr (C). Lanes: a
and h, EcoRI/BamHI pHB-11 (0.1 jig); b and i, EcoRI/BamHI pKBE-
2 (0.1 pug); c and j, BamHI AT22 (1.0 pig); d and k, BamHI AP3 (1.0 pg);
e and 1, EcoRI AL2-L11 (1.0 pg); f and m, EcoRI AL2-R7 (1.0 ,ug); g and
n, EcoRI ANPS-1-1-1 (1.0 ,ug). Size markers are in kbp.
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FIG. 3. Identification of lung and colon carcinoma transforming
genes as K-ras homologs. Six micrograms of EcoRI-digested cellular
DNA was electrophoresed through 1% agarose gels and subsequently
blotted to nitrocellulose. The filters were hybridized and washed under
stringent conditions with 32P-labeled pKBE-2 (v-K-ras) as probe. Lanes:
1, NIH 3T3 transformed with SK-CO-1 DNA; 2, NIH 3T3 transformed
with SK-LU-1 DNA; 3, NIH 3T3 transformed with Calu-1 DNA; 4, NIH
3T3; 5, T24; 6, NIH 3T3 with 50 pg of EcoRI-cleaved AL2-R7 DNA; 7,
NIH 3T3 with 50 pg of EcoRI-cleaved AL2-11 DNA. For structure of A
clones, see Fig. 4A. Size markers are in kbp.
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FIG. 4. Maps of ras-homologous regions in Calu-1 and SK-N-SH transforming genes. (A) Composite restriction endonuclease map of part of
the Calu-1 transforming gene. The map was derived from overlapping restriction endonuclease maps of inserts in A Charon 4A, some of which are
shown above and below the map. We estimate that 30% of the gene remains to be cloned. -, Restriction fragments that hybridize with the BLUR8
clone of human Alu repeat sequence DNA; EZ, restriction fragments that hybridize at high stringency to the v-K-ras clone pKBE-2. The 5' and
3' ends of the transcription unit were deduced by hybridization of the cloned Calu-1 transforming gene with 5' and 3' specific restriction endo-
nuclease fragments of pKBE-2. (B Upper) Restriction endonuclease map of the SK-N-SH transforming gene contained within ANPS-1-1-1 is taken
from Shimizu et al. (26). (B Lower) 5' flanking sequences of B Upper have undergone rearrangement, showing the restriction map of the genomic
SK-N-SH transforming sequence (26). m, Restriction fragments that hybridize with the BLUR8 clone; Z, restriction fragments that hybridize
at high stringency with the v-H-rms clone pHB-ll. The 5' and 3' orientations of the transcription unit were determined as above. Numbers show
distances in kbp. Sites for restriction endonucleases are: Ba, BamHI; Bg, Bgl II; H, Hindli; K, Kpn I; R, EcoRI; Sm, Sma I; and X, Xba I.
human lung carcinoma cell line Calu-1 was cloned into partially
overlapping A Charon 4A phages as described. A composite re-
striction endonuclease map for this gene is shown in Fig. 4A.
Three separate regions of homology to v-K-ras were deter-
mined by hybridization analysis, comprising 3.0-, 3.1-, and 2.4-
kbp EcoRI fragments (see Fig. 2, lanes 1 and m). All three v-
K-ras-related EcoRI fragments and a fourth 6.7-kbp EcoRI
fragment, which has not been cloned yet, were present in all
NIH 3T3 cells transformed with DNA from various lung and
colon carcinoma cell lines (Fig. 3, lanes 1-3, 6, and 7). These
Kirsten homologous regions do not arise by tandem gene du-
plications because they hybridized to discrete regions of the
cloned v-K-ras gene (data not shown). Indeed, hybridization
with specific v-K-ras DNA fragments allowed us to make an
unambiguous assignment of the direction of transcription (see
Fig. 4A). In contrast to the small T24 transforming gene, which
is entirely contained on a 2.9-kbp Sac I fragment (25), the trans-
forming gene of Calu-1 is probably greater than 30 kbp.
The SK-N-SH Neuroblastoma Transforming Gene Is a New
Member of the ras Gene Family. Although the SK-N-SH neu-
roblastoma transforming gene was weakly homologous to both
v-H-ras and v-K-ras, we reasoned that it may encode a protein
structurally and serologically related to Harvey and Kirsten ras
gene product. We tested this possibility by using a broadly re-
active monoclonal antibody against ras-encoded protein to im-
munoprecipitate [3S]methionine-labeled extracts from three
independently derived NIH 3T3 transformants containing the
SK-N-SH transforming gene. Immune precipitates from these
cells and from NIH 3T3 transformed by Harvey sarcoma virus
unintegrated DNA, NIH 3T3 transformed by DNAs from hu-
man lung and colon carcinoma cells, and NIH 3T3 itself were
analyzed by NaDodSO4/polyacrylamide gel electrophoresis (Fig.
5). A protein with an apparent Mr of 19,000 was seen in im-
munoprecipitates of v-H-ras-transformed NIH 3T3 (Fig. 5, lane
2) but not in NIH 3T3 controls (Fig. 5, lane 1). A similarly mi-
grating protein was seen in NIH 3T3 cells transformed with either
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FIG. 5. ras-Related proteins in NIH 3T3 transformed cells. Cells (5
x 105) were labeled for 18 hr with 80 ACi of [355]methionine and ex-
tracted with nonionic detergents, and cleared lysates were used for im-
munoprecipitation with rat anti-ras p21 monoclonal antibody Y13-259
(16). Immunocomplexes were collected onto S. aureus protein A, dis-
solved and boiled in NaDodSO4 sample buffer, and analyzed by Na-
DodSO4/polyacrylamide gel electrophoresis on a 12.5% polyacryl-
amide gel. Proteins were visualized by fluorography. Lanes: a, NIH 3T3;
b, HT14B; c and d, two NIH 3T3 lines independently transformed with
Calu-1 DNA; e-g, three NIH 3T3 lines independently transformed with
SK-N-SH DNA; h, one NIH 3T3 line transformed with SK-CO-i DNA.
A 14C-labeled protein mixture (Amersham) provided Mr standards
(shown x 10-3).
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Calu-1 or SK-CO-1 DNA (Fig. 5, lanes 3, 4, and 8). A uniquely
migrating protein with an apparent M, of 17,500 was seen in
each NIH 3T3 transformant containing the SK-N-SH trans-
forming gene (Fig. 5, lanes 5-7). This protein had an isoelectric
point similar to that found for the v-H-ras-encoded protein (data
not shown). Our findings indicate that the SK-N-SH neuro-
blastoma transforming gene is another member of the ras gene
family.
We exploited the homology between the SK-N-SH trans-
forming gene and the v-ras genes to determine its direction of
transcription and approximate regions of homology (see Fig.
4B).
DISCUSSION
Three different human transforming genes that can be detected
by the NIH 3T3 transformation assay are members of the ras
gene family. The transforming gene of a bladder carcinoma cell
line (T24) is a human homolog of the v-H-ras gene (5, 10, 11).
The transforming gene of Lx-1, a human lung carcinoma cell
line, is a human homolog of v-K-ras (5). Comparison of the work
of Der et al. (5) with ours indicates the presence of the same
transforming gene in two lung carcinoma cell lines (SK-LU-1
and Calu-1) and in .one colon carcinoma cell line (SK-CO-1).
This same gene is also detectable by DNA transfer in human
lung and colon tumors maintained in nude mice (unpublished
data) and in the colon carcinoma cell line SW480 (3, 9). The
transforming gene of a human neuroblastoma cell line (SK-N-
SH) is related to (but distinct from) the homologs of the v-H-
ras and v-K-ras genes and represents a third branch within the
ras gene family. Each branch may have more recent evolu-
tionary offshoots. Thus, Chang et al. (34) reported two human
homologs of v-H-ras (H-ras-1 and -2) and two homologs of v-
K-ras (K-ras-1 and -2). A comparison of restriction endonucle-
ase maps for these genes with the three human transforming
genes we have isolated indicates that the T24 bladder carci-
noma-transforming gene is H-ras-1, the lung and colon carci-
noma-transforming gene is probably K-ras-2, and the SK-N-SH
neuroblastoma-transforming gene is a heretofore uncharacter-
ized gene. We propose calling the human transforming gene of
SK-N-SH the N-ras-1 gene.
It is of considerable interest that a wide variety of tumor cells
contain activated ras genes, detectable by gene transfer into
NIH 3T3 cells. Several factors possibly contribute: ras trans-
forming genes may be more readily detected than other trans-
forming genes by the NIH 3T3 focus assay; ras genes may be
easily activated by mutation; and ras genes may have critical
cellular functions in a wide variety of cell types. The function
of the ras gene products is not known nor is it known whether
they perform physiologically distinguishable roles. However, it
is known that an altered amino acid sequence is responsible for
the activation of the H-ras-1 gene of T24 (25, 35, 36), and we
speculate that alteration in the ras gene products may be a com-
mon step in many forms of human cancer.
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